MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
214.17
+2.59
+1.22%
After Hours: 214.50 +0.33 +0.15% 18:51 12/15 EST
OPEN
210.35
PREV CLOSE
211.58
HIGH
215.19
LOW
209.01
VOLUME
8.47M
TURNOVER
--
52 WEEK HIGH
215.19
52 WEEK LOW
136.50
MARKET CAP
516.00B
P/E (TTM)
20.67
1D
5D
1M
3M
1Y
5Y
1D
Johnson & Johnson Gets Target Hike, But BofA Flags Modest Pipeline Impact
Benzinga · 5h ago
Bristol Myers Trades At Trough Valuation — Analyst Says Pipeline Upside Is Being Ignored
Benzinga · 5h ago
J&J Tecvayli/Darzalex combo granted FDA national priority voucher
Seeking Alpha · 7h ago
FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer
NASDAQ · 8h ago
FDA Proactively Awards National Priority Voucher Based On Strong Phase 3 Study Results
Benzinga · 8h ago
Johnson & Johnson (JNJ) Is Considered a Good Investment by Brokers: Is That True?
NASDAQ · 9h ago
Johnson & Johnson Wins FDA Nod For First Precision Combo For Mutated Prostate Cancer
Benzinga · 9h ago
3 Best ETFs to Invest In, According to AI Analyst, 12/15/2025
TipRanks · 9h ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.